ALS ONE is an unprecedented partnership of the world’s leaders in ALS from Massachusetts General Hospital, UMass Medical Center, Harvard Medical School, ALS Therapy Development Institute, and CCALS. ALS ONE's team includes Dr. Merit Cudkowicz, Chief of Neurology at Mass. General, Julieanne Dorn, Professor of Neurology at Harvard Medical School, Dr. Robert Brown, Professor and Chair of Neurology at the University of Massachusetts Medical Center and Medical School, Dr. Steven Perrin, Chief Executive Officer and Chief Scientific Officer at ALS Therapy Development Institute, Dr. Nazem Atassi, Associate Director of the Neurological Clinical Research Institute (NCRI) at MGH, and Assistant Professor of Neurology at Harvard Medical School, Dr. James Barry, Co-Director of teh MGH Neuromuscular Division and of the MGH ALS
Together, this team has joined forces on a shared Science and Care Plan. An approach to a disease to this extent has never been taken. They have committed to finding a treatment or cure for ALS by the year 2020, with proper funding, while improving the care model for those living with ALS now.